Categories: Health

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

 | Source: Milestone Scientific, Inc.

ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, August 15th, 2025, to discuss the company’s financial results for the second quarter ended June 30, 2025, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 470429. A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/52876.

An audio replay of the call will be available through Friday, August 29th, 2025, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 52876.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Contact:
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

GlobeNews Wire

Recent Posts

MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm",…

39 minutes ago

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

Product sales and commercial rights revenues in 2025 increased 90% year-over-year to US$82.1 million (RMB574.1…

39 minutes ago

Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation

SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage…

39 minutes ago

THE CHAIRMAN IN HONG KONG IS NAMED NO.1 IN THE LIST OF ASIA’S 50 BEST RESTAURANTS 2026

Hong Kong's The Chairman reclaims the title of The Best Restaurant in Asia, sponsored by…

2 hours ago

Esports Nations Cup 2026 Awards Official Partner Status Across 100+ Nations to Build the Future of Nation-Based Esports

New global framework unites federations, clubs and ecosystem leaders to form national teams and mobilize…

7 hours ago

DeriW Launches Edge Hour: Time-Limited Trading Challenge with $1M Prize Pool

HONG KONG, March 25, 2026 /PRNewswire/ -- DeriW, a decentralized perpetual derivatives trading platform incubated…

7 hours ago